Prescription medication · ARB / CCB / Diuretic Triple

olmesartan/amlodipine/hydrochlorothiazide

Also sold as Tribenzor. Tribenzor is used to treat high blood pressure (hypertension).

Data updated 2026-05-15

10
InteractionsSeveral interactions
$16.15
Brand price (NADAC)

olmesartan/amlodipine/hydrochlorothiazide (Tribenzor) is a prescription ARB / CCB / Diuretic Triple. Tribenzor is used to treat high blood pressure (hypertension).

Tribenzor is a drug that combines three medicines to lower high blood pressure. Lowering blood pressure helps prevent strokes and heart attacks.

Drug Pricing (NADAC)

Brand Price

$16.15/unit

Generic Available

No

Pricing data from NADAC (CMS), effective September 20, 2024. Compare all drug costs →

Compare with Another Drug →

What it does

Tribenzor is used to treat high blood pressure (hypertension).

Common side effects

Dizziness, Swelling in your hands, ankles, or feet, Headache

Key warnings

If you are pregnant or plan to become pregnant, stop taking Tribenzor and tell your doctor right away.

The sections below are summarized in plain English from olmesartan/amlodipine/hydrochlorothiazide's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Tribenzor contains three medicines that work in different ways to lower blood pressure. Olmesartan blocks a hormone that tightens blood vessels. Amlodipine relaxes and widens blood vessels, and hydrochlorothiazide removes extra water and salt from your body.

Serious Warnings

If you are pregnant or plan to become pregnant, stop taking Tribenzor and tell your doctor right away. This medicine can harm or even cause death to your unborn baby.

Known Drug Interactions

Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. Do not co-administer aliskiren with Tribenzor in patients with diabetes [See Contraindications ( 4 )] . Avoid use of aliskiren with Tribenzor in patients with renal impairment (GFR <60 ml/min).

Mechanism: Both drugs target the same system that regulates blood pressure, which can lead to dangerously low blood pressure or kidney damage. This combination also makes it harder for the body to get rid of potassium.

moderate olmesartan

7 DRUG INTERACTIONS Olmesartan medoxomil ( 7.1 ): Nonsteroidal anti-inflammatory drugs (NSAIDS): May lead to increased risk of renal impairment and loss of antihypertensive effect. Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose. 1 Drug Interactions with Olmesartan Medoxomil Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of...

Mechanism: Taking two medicines that contain the same active ingredient can cause your blood pressure to drop too low. It can also cause your kidneys to stop working properly or lead to dangerous levels of potassium.

Amlodipine ( 7.2 ): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3 ): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.

Mechanism: Taking both medications increases the total amount of amlodipine in your body, which can cause your blood pressure to drop too low.

Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3 ): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin) : Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins : Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.

Mechanism: Using these together increases the total amount of diuretic in your body, which can change your blood sugar or mineral levels.

Amlodipine ( 7.2 ): Limit simvastatin to 20 mg daily when coadministered. 2 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.

Mechanism: Amlodipine can cause simvastatin to build up in your body by slowing down how it is processed.

Check all your medications →

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

What should I do if I feel dizzy after taking Tribenzor?
Lie down until the dizziness passes. Talk to your doctor if dizziness continues.
Can I take Tribenzor if I have diabetes?
You should not take Tribenzor with aliskiren if you have diabetes.
Will Tribenzor interact with other medications I am taking?
Yes, Tribenzor can interact with other medications. Tell your doctor about all the medicines you take, including over-the-counter drugs and supplements.
Can I drink alcohol while taking Tribenzor?
Alcohol may lower your blood pressure further and increase dizziness. Talk to your doctor about alcohol consumption.
What if I have kidney problems?
Talk to your doctor. If your creatinine clearance is ≤30 mL/min, avoid use.
Can Tribenzor cause allergic reactions?
Yes, if you are hypersensitive to sulfonamide-derived drugs, you should not take Tribenzor.
How long does it take for Tribenzor to lower my blood pressure?
It may take a few weeks for Tribenzor to fully lower your blood pressure. Continue taking it as prescribed, even if you feel well.
What lifestyle changes can help lower my blood pressure while taking Tribenzor?
Follow a healthy diet, exercise regularly, quit smoking, and limit sodium intake.
Can Tribenzor cause changes in my potassium levels?
Yes, Tribenzor can affect potassium levels. Your doctor will monitor your potassium levels with blood tests.
What are the symptoms of acute angle-closure glaucoma?
Symptoms can include eye pain, vision changes, and redness in the eye.
What are the common side effects of olmesartan/amlodipine/hydrochlorothiazide?
The registry lists Dizziness, Swelling in your hands, ankles, or feet, Headache, Feeling tired, Runny or stuffy nose among the most-reported FAERS reaction terms for olmesartan/amlodipine/hydrochlorothiazide. These counts are not an individual symptom assessment.
Does olmesartan/amlodipine/hydrochlorothiazide interact with other medications?
The registry has 10 documented interaction rows for olmesartan/amlodipine/hydrochlorothiazide. Notable source-record pairings include aliskiren, olmesartan, amlodipine. These rows are not a complete medication review.
What drug class is olmesartan/amlodipine/hydrochlorothiazide?
olmesartan/amlodipine/hydrochlorothiazide belongs to the ARB / CCB / Diuretic Triple drug class. It requires a prescription (Rx). Tribenzor is used to treat high blood pressure (hypertension).
What pregnancy or breastfeeding source fields are listed for olmesartan/amlodipine/hydrochlorothiazide?
The FDA label for olmesartan/amlodipine/hydrochlorothiazide contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.

Other drugs grouped near olmesartan/amlodipine/hydrochlorothiazide - same-class peers and common alternatives.

Compare olmesartan/amlodipine/hydrochlorothiazide vs acebutolol side-by-side →

Medication Guides

Save on olmesartan/amlodipine/hydrochlorothiazide

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for olmesartan/amlodipine/hydrochlorothiazide

The FDA label for olmesartan/amlodipine/hydrochlorothiazide (sold under brand names such as Tribenzor) classifies it as a prescription-only medication in the ARB / CCB / Diuretic Triple class. Tribenzor is used to treat high blood pressure (hypertension). Official labeling lists 11 commonly reported side effects, including Dizziness, Swelling in your hands, ankles, or feet, Headache.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 10 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: July 12, 2023

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page